AmSurg Announces Pricing of Offering of 5,500,000 Shares of Common Stock
December 01 2015 - 6:30PM
Business Wire
AmSurg Corp. (“AmSurg”) (NASDAQ: AMSG) today announced that it
has priced its underwritten public offering of 5,500,000 shares of
its common stock at a price of $80.00 per share. The net proceeds
from the offering will be approximately $422 million, after
estimated issuance discounts and commissions. AmSurg intends to use
the net proceeds from the offering to repay outstanding
indebtedness under its revolving credit facility borrowed to fund
its recent acquisitions, to fund a portion of the approximately
$500 million of acquisition opportunities in its pipeline that are
under letter of intent and targeted to close between now and the
end of the first quarter of 2016 and for other general corporate
purposes. In addition, AmSurg has granted the underwriters a 30-day
option to purchase up to an additional 825,000 shares of its common
stock.
SunTrust Robinson Humphrey and J.P. Morgan are acting as lead
joint book-running managers for the offering. BMO Capital Markets,
Jefferies and Guggenheim Securities are acting as joint
book-running managers, and Baird, Avondale Partners, KeyBanc
Capital Markets, Piper Jaffray and Raymond James are acting as
co-managers. The offering is being made pursuant to an effective
shelf registration statement filed with the Securities and Exchange
Commission (“SEC”). The offering will be made only by means of a
prospectus supplement and the accompanying base prospectus, copies
of which may be obtained by contacting (i) SunTrust Robinson
Humphrey, 3333 Peachtree Road NE, 9th Floor, Atlanta, GA 30326,
Attention: Prospectus Department; email:
strh.prospectus@suntrust.com; telephone: 404-926-5744; or fax:
404-926-5464 or (ii) J.P. Morgan Securities LLC, c/o Broadridge
Financial Solutions, 1155 Long Island Avenue, Edgewater, NY 11717,
or telephone: 866-803-9204. These documents will also be filed with
the SEC and will be available at the SEC’s website at
http://www.sec.gov.
The press release shall not constitute an offer to sell or a
solicitation of an offer to buy the securities described herein,
nor shall there be any sale of these securities in any state or
other jurisdiction in which such an offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the federal securities laws, including statements
related to the expected use of the net proceeds therefrom, which
are based on current expectations, forecasts and assumptions that
involve risks and uncertainties that could cause actual outcomes
and results to differ materially. Forward-looking statements relate
to expectations, beliefs, projections, future plans and strategies,
anticipated events or trends and similar expressions concerning
matters that are not historical facts. In some cases, you can
identify forward-looking statements by the use of forward-looking
terminology such as “may,” “will,” “should,” “expects,” “intends,”
“plans,” “anticipates,” “believes,” “estimates,” or “predicts,” or
the negative of these words or phrases or similar words or phrases,
which are predictions of or indicate future events or trends and
which do not relate solely to historical matters. While
forward-looking statements reflect AmSurg’s good faith beliefs,
assumptions and expectations, they are not guarantees of future
performance. Furthermore, AmSurg disclaims any obligation to
publicly update or revise any forward-looking statement to reflect
changes in underlying assumptions or factors, of new information,
data or methods, future events or other changes. These
forward-looking statements are based on a variety of assumptions
that may not be realized and that are subject to significant risks
and uncertainties, including that the acquisitions may not be
consummated and that the anticipated financial and strategic
benefits of the acquisitions may not be realized, as well as risks
and uncertainties referenced from time to time in the Company’s
filings with the SEC.
About AmSurg Corp.
AmSurg’s Ambulatory Services Division acquires, develops and
operates ambulatory surgery centers in partnership with physicians
throughout the U.S. AmSurg’s Physician Services Division, Sheridan,
provides outsourced physician services in multiple specialties to
hospitals, ASCs and other healthcare facilities throughout the
U.S., primarily in the areas of anesthesiology, children’s
services, emergency medicine and radiology. Through these
businesses as of September 30, 2015, AmSurg owned and operated 253
ASCs and one surgical hospital in 34 states and provided physician
services to more than 360 healthcare facilities in 27 states.
AmSurg has partnerships with, or employs, over 5,000 physicians in
38 states and the District of Columbia.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151201006871/en/
AmSurg Corp.Claire M. Gulmi, 615-665-1283Executive Vice
President and Chief Financial Officer
Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart
From Jul 2023 to Jul 2024